Showing results (221-230 of 1,842) with videos related to
Sort By:
Pageof 185
Journal of Managed Care & Specialty Pharmacy|September 30, 2020
The Effect of Dose Escalation on the Cost-Effectiveness of Etanercept and Adalimumab with Methotrexate Among Patients with Moderate to Severe Rheumatoid ArthritisDevin Incerti, Ervant J Maksabedian Hernandez, Joseph Tkacz, et al.Journal of Managed Care & Specialty Pharmacy|September 30, 2020
Understanding the Socioeconomic and Geographical Characteristics of Beneficiaries Receiving a Comprehensive Medication ReviewJoshua Chou, Karen Pellegrin, Catherine E Cooke, et al.Journal of Managed Care & Specialty Pharmacy|November 28, 2018
State Approaches to Therapeutic Interchange in Community Pharmacy Settings: Legislative and Regulatory AuthorityThomas Vanderholm, Donald Klepser, Alex J AdamsJournal of Managed Care & Specialty Pharmacy|December 25, 2018
Gene Therapy for Spinal Muscular Atrophy: An Emerging Treatment Option for a Devastating DiseaseVamshi K Rao, Daniel Kapp, Mary SchrothJournal of Managed Care & Specialty Pharmacy|December 28, 2018
The Effectiveness and Value of Patisiran and Inotersen for Hereditary Transthyretin AmyloidosisKristin Mickle, Karen E Lasser, Jeffrey S Hoch, et al.Journal of Managed Care & Specialty Pharmacy|December 28, 2018
TTR Gene Silencers for Hereditary ATTR Amyloidosis: More than ICER RecognizedJohn L BerkJournal of Managed Care & Specialty Pharmacy|October 31, 2019
Reflections on the ISPOR Special Task Force on U.S. Value Frameworks: Implications of a Health Economics Approach for Managed Care PharmacyLouis P Garrison, Peter J Neumann, Richard J WillkeJournal of Managed Care & Specialty Pharmacy|October 29, 2020
ICER's assessment of lasmiditan, rimegepant, and ubrogepant for acute migraineMeg Franklin, Eric DruytsJournal of Managed Care & Specialty Pharmacy|October 29, 2020
Evolution of ACO readiness to optimize medication use: are we there yet?Kimberly Westrich, Lisabeth BueltJournal of Managed Care & Specialty Pharmacy|October 29, 2020
Healthcare resource utilization and cost among patients with type 1 diabetes in the United StatesJason C Simeone, Surbhi Shah, Michael L Ganz, et al.Pageof 185